Latest news with #Eyam
Yahoo
25-05-2025
- Yahoo
English village where lovers were separated by plague is now a haven for dark tourism
A quaint village in Derbyshire has become a hotspot for dark tourism, owing to its sorrowful past that traces back to the Black Death in the 1660s. Over the centuries, the Peak District hamlet of Eyam has earned the moniker 'plague village', following the demise of 260 villagers within a span of 14 months. The bubonic plague, which first swept across the globe in the 1300s, has claimed innumerable lives. A particularly catastrophic outbreak engulfed England in the 1660s, causing over 68,000 fatalities in London alone. Eventually, this lethal contagion reached Eyam in the summer of 1665. In an act of self-sacrifice to safeguard neighbouring villages, the inhabitants of Eyam chose to isolate themselves from the surrounding settlements. READ MORE: The beautiful UK hidden gem that's reminiscent of a scene from a Disney movie READ MORE: One of UK's best beaches has a dark past and is a 'graveyard' for 300 ships A boundary stone, still visible today, was erected between Eyam, plagued by the disease, and the nearby unaffected town of Stoney Middleton. At this stone, Eyam's residents would deposit vinegar-soaked money in exchange for food and medical supplies, provided by the people of Stoney Middleton. Modern-day visitors to Eyam can witness the enduring impact of the plague, with numerous graves scattered throughout the village and adjacent fields. Families were urged to inter their deceased relatives near their homes instead of the church graveyard. Jackie Todd, a recent visitor to Eyam, took to Instagram to share a heartbreaking love tale that has become woven into the folklore of the plague-stricken village of Eyam. View this post on Instagram A post shared by Jackie Todd (@jackietodd_) In a video recounting this story from her visit, Jackie penned: "In 1665, the plague hit Eyam and they locked down the village, separating Emmott Sydall from her fiancé Rowland Torre. "Once a week, Emmott and Rowland met at the village boundary, at a distance so he wouldn't catch the disease. One day, Emmott didn't show up. When the lockdown lifted, Rowland was one of the first to enter the village looking for Emmott." She then displayed a plaque indicating that Emmott was tragically among those who succumbed to the black death. The star-crossed lovers and their rendezvous at the village boundary have been eternally captured in a stained glass depiction visible in Eyam's St Lawrence's Church.
Associated Press
10-02-2025
- Business
- Associated Press
Eyam Health Announces Interim Results on Antibody Therapeutics, Secures Extension of Foundation Funding
VANCOUVER, CANADA, February 10, 2025 / / -- Eyam Health is excited to announce promising interim results from an ongoing study funded by the Gates Foundation, leading to an extension of grant funding to further Eyam's research. The full results will mark an important milestone, validating the Gemini Platform for the effective and efficient delivery of antibody therapeutics without the need for lipid nanoparticles (LNPs) and demonstrating a significant increase in the duration of antibody expression. Interim Results Show Promise of Gemini's Potential The interim results have exceeded the key performance benchmark, showing high levels of antibody production and sustained expression over the study's timepoints. The full study results will aim to confirm that Eyam's Gemini platform can deliver life-saving therapeutics more efficiently, eliminating the reliance on LNPs—one of the primary limitations of conventional nucleic acid-based therapies. Encouraged by these strong results, Eyam Health is extending the study to six months to further evaluate the platform's long-term expression capabilities. Continued Support from the Gates Foundation This support enables Eyam to accelerate progress and further validate the Gemini Platform's ability to revolutionize global healthcare. Eyam CEO, Ryan M. Thomas responded to the results by saying, 'These interim results offer a promising outlook for the entire field of nucleic acid-based therapeutics. The study is being extended and will inform us of Gemini's ability to deliver high levels of antibodies without lipid nanoparticles while extending their duration in the body. We are grateful for the Gates Foundation's continued funding support as we advance this work toward real-world impact.' About Eyam Health Founded in 2020, Eyam Health is an emerging leader in next-generation vaccine and therapeutic platform technologies. Our Gemini and Jennerator platforms power groundbreaking advancements in infectious disease, oncology, chronic disease, and animal health. By pioneering self-amplifying nucleic acid delivery, Eyam is shaping the future of medicine, making innovative health solutions more effective, accessible, and durable. Samad Raza Eyam Health +1 604-767-4890 Legal Disclaimer:
